Citation: | XIE Chunxiao, LU Jiexia, CHEN Fengping, WEI Dafu, SHI Qiuyue, QIN Shanyu. Correlation study of metabolic syndrome with clinicopathological features and prognosis in patients with pancreatic cancer[J]. Journal of Guangxi Medical University, 2024, 41(1): 78-84. DOI: 10.16190/j.cnki.45-1211/r.2024.01.011 |
[1] |
XIA C, DONG X, LI H, et al.Cancer statistics in China and United States, 2022:profiles, trends, and determinants[J].Chinese medical journal, 2022, 135(5):584-590.
|
[2] |
SUNG H, FERLAY J, SIEGEL R L, et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA:a cancer journal for clinicians, 2021, 71(3):209-249.
|
[3] |
ISHII Y, SERIKAWA M, TSUBOI T, et al.Role of Endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the diagnosis of pancreatic cancer[J].Diagnostics(Basel, Switzerland), 2021, 11(2).
|
[4] |
AMBROSELLI D, MASCIULLI F, ROMANO E, et al.New advances in metabolic syndrome, from prevention to treatment:the role of diet and food [J].Nutrients, 2023, 15(3):640.
|
[5] |
KARRA P, WINN M, PAULECK S, et al.Metabolic dysfunction and obesity-related cancer:Beyond obesity and metabolic syndrome[J].Obesity, 2022, 30(7):1323-1334.
|
[6] |
诸骏仁, 高润霖, 赵水平, 等.中国成人血脂异常防治指南(2016 年修订版)[J].中国循环杂志, 2016, 31 (10):937-953.
|
[7] |
中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志, 2007, 35(5):390-419.
|
[8] |
ZHONG L, LIU J, LIU S, et al.Correlation between pancreatic cancer and metabolic syndrome:A systematic review and meta-analysis [J].Frontiers in endocrinology, 2023, 14:1116582.
|
[9] |
XIA B, HE Q, PAN Y, et al.Metabolic syndrome and risk of pancreatic cancer:A population-based prospective cohort study[J].International journal of cancer, 2020, 147(12):3384-3393.
|
[10] |
WANG D S, WANG Z Q, ZHANG L, et al.Are risk factors associated with outcomes in pancreatic cancer? [J].PLos one, 2012, 7(7):e41984.
|
[11] |
KHALAF N, KRAMER J, LIU Y, et al.Diabetes status and pancreatic cancer survival in the nationwide veterans affairs healthcare system [J].Digestive diseases and sciences, 2023, 68(9):3634-3643.
|
[12] |
HE X Y, LI J F, YAO W Y, et al.Resolution of new-onset diabetes after radical pancreatic resection predicts longterm survival in patients with pancreatic ductal cell adenocarcinoma [J].Annals of surgical oncology, 2013, 20(12):3809-3816.
|
[13] |
BEN Q, XU M, JIANG Y, et al.Clinical profiles and longterm outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus [J].Diabetes/metabolism research and reviews, 2012, 28(2):169-176.
|
[14] |
LEE D H, GIOVANNUCCI E L.The obesity paradox in cancer:epidemiologic insights and perspectives [J].Current nutrition reports, 2019, 8(3):175-181.
|
[15] |
LAUBY-SECRETAN B, SCOCCIANTI C, LOOMIS D, et al.Body fatness and cancer-viewpoint of the iarc working group [J].The New England journal of medicine, 2016, 375(8):794-798.
|
[16] |
BAO B, WANG Z, LI Y, et al.The complexities of obesity and diabetes with the development and progression of pancreatic cancer [J].Biochimica et biophysica acta, 2011, 1815(2):135-146.
|
[17] |
RUZE R, SONG J, YIN X, et al.Mechanisms of obesityand diabetes mellitus-related pancreatic carcinogenesis:a comprehensive and systematic review[J].Signal transduction and targeted therapy, 2023, 8(1):139.
|
[18] |
WU B, SHEN W, WANG X, et al.Plasma lipid levels are associated with the CD8+T-cell infiltration and prognosis of patients with pancreatic cancer [J].Cancer medicine, 2023, 12(13):14138-14148.
|
[19] |
KABAT G C, KIM M Y, CHLEBOWSKI R T, et al.Serum lipids and risk of obesity-related cancers in postmenopausal women [J].Cancer causes & control, 2018, 29(1):13-24.
|
[20] |
杨 健, 樊知遥, 李永政, 等.胰腺癌患者的血脂谱特点及其与临床和病理学特征的相关性分析[J].中华外科杂志, 2022, 60(7):680-687.
|
[21] |
OBERLE R, KÜHRER K, ÖSTERREICHER T, et al.The HDL particle composition determines its antitumor activity in pancreatic cancer [J].Life science alliance, 2022, 5(9):e202101317.
|
[22] |
邓 青, 程蔚蔚, 陈 岚.高密度脂蛋白胆固醇、铁蛋白、整合素α3 与Ⅳ期非小细胞肺癌病理特征及患者生存预后的相关性[J].实用癌症杂志, 2022, 37(10):1591-1595.
|
[23] |
范大光, 梁焕芳, 马剑方.血清脂蛋白与胃癌淋巴结转移及肿瘤分期的关系[J].肿瘤研究与临床, 2011, 23(7):447-449.
|
[24] |
韩金星, 韩 荣.PA、LDH 和HDL-C 表达水平与晚期结直肠癌近期疗效和病情进展的相关性[J].中国肛肠病杂志, 2022, 42(4):16-18.
|
[25] |
LIAO F, HE W, JIANG C, et al.A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C [J].Oncotargets and therapy, 2015, 8:3135-3142.
|